Skip to main content

Hemorrhagic Microangiopathy clinical trials at UCSF

1 research study open to eligible people

Showing trials for
  • Biomarkers of CASH

    open to eligible people ages 18 years and up

    The project aims to develop prognostic and diagnostic blood tests for symptomatic brain hemorrhage in patients diagnosed with cavernous angiomas, a critical clinical challenge in a disease affecting more than a million Americans. We further examine whether blood biomarkers can replace or enhance the accuracy of advanced imaging in association with lesional bleeding. The project tests a novel integrational approach of biomarker development in a mechanistically defined cerebrovascular disease, with a clinically relevant context of use.

    San Francisco, California and other locations

Last updated: